Für diesen Artikel ist leider kein Bild verfügbar.

Promoting Safe and Effective Genetic Testing in the United States

Final Report of the Task Force on Genetic Testing
Buch | Hardcover
204 Seiten
1998
Johns Hopkins University Press (Verlag)
978-0-8018-5952-6 (ISBN)
55,50 inkl. MwSt
In view of the uncertainty of genetic test results, a task force was set up and charged with reviewing genetic testing in the US and making recommendations for the development of safe and effective testing. This work presents the conclusions of their study.
Despite remarkable progress, much remains unknown about the risks and benefits of genetic testing. No effective interventions are yet available to improve the outcome of most inherited diseases; negative test results might not rule out future occurrence of disease, and positive test results do not necessarily mean the disease will inevitably develop. In view of this uncertainty, the Working Group on Ethical, Legal and Social Implications of Human Genome Research at the National Institutes of Health and Department of Energy created the Task Force on Genetic Testing. Comprising representatives of 15 major stakeholders in genetic testing and five government agencies involved with testing, the task force was charged with reviewing genetic testing in the United States and making recommendations to ensure the development of safe and effective genetic tests. In "Promoting Safe and Effective Genetic Testing in the United States" the members of this task force present the conclusions of their study. They begin by describing general principles involved in genetic testing, including informed consent, testing of children, confidentiality, and discrimination.
They describe methods and policies to ensure the safety and effectiveness of new genetic tests, including criteria for developing tests and ways of ensuring compliance with those criteria. They then discuss how to ensure the quality of laboratories that perform genetic tests, including the role of laboratory personnel and methods of monitoring laboratory performance. They show how health care professionals outside the field of genetics can better understand the uses of genetic testing, and offer suggestions for changes in these professionals' education and training. Finally, they offer a look at testing for rare inherited genetic disorders.

Neil A. Holtzman, M.D., M.P.H., is professor of pediatrics at the Johns Hopkins University School of Medicine. He holds joint appointments in Health Policy and Epidemiology at the Johns Hopkins School of Hygiene and Public Health and is director of Genetics and Public Policy Studies at the Johns Hopkins Medical Institutions. Michael S. Watson, Ph.D., is with the American College of Medical Genetics.

Erscheint lt. Verlag 18.9.1998
Verlagsort Baltimore, MD
Sprache englisch
Maße 216 x 279 mm
Gewicht 907 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Laboratoriumsmedizin
Studium 2. Studienabschnitt (Klinik) Humangenetik
ISBN-10 0-8018-5952-2 / 0801859522
ISBN-13 978-0-8018-5952-6 / 9780801859526
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Eine sehr persönliche Geschichte | Der New York Times-Bestseller

von Siddhartha Mukherjee

Buch | Softcover (2023)
Ullstein Taschenbuch Verlag
21,99
Die revolutionäre Medizin von morgen (Lifespan)

von David A. Sinclair; Matthew D. LaPlante

Buch | Softcover (2020)
DuMont Buchverlag
16,00